Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells
Leukemia ( IF 12.8 ) Pub Date : 2024-05-22 , DOI: 10.1038/s41375-024-02281-z Nabih Maslah 1, 2 , Salome Rety 1 , Melina Bonnamy 1 , Lorea Aguinaga 3 , Tony Huynh 3 , Veronique Parietti 4 , Stephane Giraudier 1, 2 , Pierre Fenaux 3 , Bruno Cassinat 1, 2
中文翻译：
氯硝柳胺联合阿扎胞苷靶向 TP53 突变的 MDS/AML 细胞
更新日期：2024-05-23
Leukemia ( IF 12.8 ) Pub Date : 2024-05-22 , DOI: 10.1038/s41375-024-02281-z Nabih Maslah 1, 2 , Salome Rety 1 , Melina Bonnamy 1 , Lorea Aguinaga 3 , Tony Huynh 3 , Veronique Parietti 4 , Stephane Giraudier 1, 2 , Pierre Fenaux 3 , Bruno Cassinat 1, 2
Affiliation
|
中文翻译：
氯硝柳胺联合阿扎胞苷靶向 TP53 突变的 MDS/AML 细胞
京公网安备 11010802027423号